Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-like protein KRT222 is a predicted structural protein that is encoded by the KRT222 gene in humans, located on chromosome 17q21.2. It is predicted to be part of the intermediate filament protein family, similar to other keratins that provide structural support within cells[1][2][3][8]. This gene has also been described as a pseudogene (KRT222P). There is no evidence that KRT222 is a receptor, enzyme, transporter, or established drug target. Its biological function is currently predicted rather than experimentally validated, and no disease associations or drug interactions are well established in scientific literature[1][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-like protein KRT222 (KRT222).